Lupin Limited (NSE:LUPIN)
India
· Delayed Price · Currency is INR 1,984.10
-15.50 (-0.78%)
Jun 9, 2025, 2:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Pharmaceuticals | 199.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 19.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter Segment Revenue | -15.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 671.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 671.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Other | 55.89B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 15.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 73.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 10.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 71.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 37.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 55.89B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 15.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|